Antiretroviral therapy in Thai adults and children with HIV-1 infection

Antiretroviral therapy in Thai adults and children with HIV-1 infection

Authors	J. Ananworanich
Supervisors	J.M.A. Lange P. Phanuphak
Cosupervisors	B. Hirschel
Award date	10-01-2008
Number of pages	153
Organisations	Faculty of Medicine (AMC-UvA)
Document type	PhD thesis
Note	Research conducted at: Universiteit van Amsterdam
Language	English
Downloads	Thesis Cover Titlepage Table of Contents Chapter 1: General introduction Chapter 2: Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily Chapter 3: Saquinavir trough concentration before and after switching NRTI to tenofovir in patients treated with once-daily saquinavir hard gel capsule/ritonavir 1600 mg/100 mg Chapter 4: A prospective study of efficacy and safety of once-daily saquinavir/ritonavir plus two nucleoside reverse transcriptase inhibitors in treatment-naive Thai patients Chapter 5: Absence of resistance mutations in antiretroviral-naive patients treated with ritonavir-boosted saquinavir Chapter 6: Incidence and risk factors for rash in Thai patients randomized to regimens with nevirapine, efavirenz or both drugs Chapter 7: No change in calculated creatinine clearance after tenofovir initiation among Thai patients Chapter 8: Highly active antiretroviral therapy (HAART) retreatment in patients on CD4-guided therapy achieved similar virological suppression compared with patients on continuous HAART. The HIV Netherlands Australia Thailand Research Collaboration 001.4 Study Chapter 9: Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial Chapter 10: CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial Chapter 11: Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment Chapter 12: Recurring thrombocytopenia associated with structured treatment interruption in patients with human immunodeficiency virus infection Chapter 13: Pharmacokinetics and 24-week efficacy/safety of dual boosted saquinavir/lopinavir/ritonavir in nucleoside-pretreated children Chapter 14: Creation of a drug fund for post-clinical trial access to antiretrovirals Chapter 15: Summary and General Discussion Samenvatting Acknowledgement List of publications Biography
Permalink to this page

Back

UvA-DARE

Digital Academic Repository

Antiretroviral therapy in Thai adults and children with HIV-1 infection